Monday, October 26, 2026 · Daily editionET --:--:--

Stopped early

Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma

NCT02225496 · M.D. Anderson Cancer Center · Updated 15 Dec 2017

What is being tested
Transoral Robotic Surgery (TORS); Modified Barium Swallow (MBS); Questionnaires
For
Oropharyngeal Cancer
Kind of study
Tests a treatment or device on volunteers. Phase 2.
Who can join
Ages 18 years and older. About 1 people. The full rules are on the registry page.
Where
United States
When
Starts or started 23 Sept 2014, ends 8 Dec 2017. Registered 26 Aug 2014.
Results
None posted yet.

In the researchers' words

Standard-of-care treatment options for oropharyngeal cancer often result in long-term side effects that interfere with normal quality of life. A minimally-invasive transoral robotic surgery (TORS) approach has been developed to operate on the disease site while affecting the surrounding tissue as little as possible. Researchers think that this approach may help to control the disease and avoid such long-term side effects. The goal of this clinical research study is to learn if minimally-invasive transoral robotic surgery (TORS) can help to control HPV-positive oropharyngeal cancer. Transoral means through the mouth. The TORS approach is called the Intuitive Surgical da Vinci Surgical System. Researchers also want to learn if this surgery affects participants' ability to speak and swallow.
ClinicalTrials.gov, NCT02225496

Sites

  • University of Texas MD Anderson Cancer CenterHouston, Texas, United States